In a significant victory for the dietary supplement industry and a reversal from a 2022 determination, the U.S. Food and Drug Administration this month confirmed that nicotinamide mononucleotide (NMN) can be marketed as a dietary supplement.
The Natural Products Association in
partnership with SupplySide Global invites you to attend the ultimate destination for supplement, food and beverage innovation.
In a significant victory for the dietary supplement industry and a reversal from a 2022 determination, the U.S. Food and Drug Administration this month confirmed that nicotinamide mononucleotide (NMN) can be marketed as a dietary supplement.
“The more people we have advocating for natural products will make our efforts even more successful and our industry even stronger. All industry members should take every opportunity to participate and make a significant difference in the success of the industry.”
Manufacturers of dietary supplement products must submit reports of “serious adverse events” to FDA.
One common myth is that FDA doesn’t oversee or regulate dietary supplement products.
FDA and FTC share responsibility for the oversight of dietary supplements and related promotion.
STORE LOCATOR
BUYERS GUIDE
Join the VOICE of the natural products industry that represents more than 10,000 retail, manufacturing, wholesale, and distribution locations.
